• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Cefuroxime Sodium

Cefuroxime Sodium

Product ID C1624
Cas No. 56238-63-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $120.60 In stock
5 g $402.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Cefuroxime is a second generation semi-synthetic cephalosporin antibiotic that inhibits penicillin binding proteins. Cefuroxime is a β-lactam antibiotic that exhibits antibacterial activity against gram positive and gram negative bacteria, including species of Haemophilus, Enterobacteriaceae, Staphylococcus, and Klebsiella. Cefuroxime also displays immunomodulatory activity, as it downregulates expression of genes associated with Th2 and Treg differentiation in vitro.

Product Info

Cas No.

56238-63-2

Purity

≥98%

Formula

C16H15N4O8SNa

Formula Wt.

446.37

Chemical Name

Monosodium (6R, 7R)-3-carbamoyloxymethyl-7-[(Z)-2-furan-2-yl-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2carboxylate

IUPAC Name

sodium;(6R, 7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl] amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Solubility

Water, methanol

Appearance

White to yellowish crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

C1624 MSDS PDF

Info Sheet

C1624 Info Sheet PDF

References

Mor F, Cohen IR. Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2981-6. PMID: 23382225.

Abdullah FE, Mushtaq A, Irshad M, et al. Current efficacy of antibiotics against Klebsiella isolates from urine samples - a multi-centric experience in Karachi. Pak J Pharm Sci. 2013 Jan;26(1):11-5. PMID: 23261722.

Sykes RB, Griffiths A, Ryan DM. Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae. Antimicrob Agents Chemother. 1977 Apr;11(4):599-604. PMID: 301007.

Eykyn S, Jenkins C, King A, et al. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother. 1976 Apr;9(4):690-5. PMID: 1267441.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P0144

    Paliperidone

    D2 and 5-HT2A antagonist.

    ≥97%
  • S771339

    STING Agonist-12

    STING activator

    ≥99%
  • A7333

    Asiaticoside

    Triterpene found in Centella, prevents melanoge...

    ≥90%
  • G346851

    Givinostat Hydrochloride

    Non-selective HDAC inhibitor.

    ≥98%
  • A9834

    Azithromycin Dihydrate

    Azalide macrolide; protein translation inhibito...

    ≥98%
  • P1869

    Perindopril Erbumine

    ACE inhibitor.

    ≥95%
  • G1658

    Gentamycin Sulfate

    Aminoglycoside; protein translation inhibitor.<...

  • S0500

    SB-203580

    p38 MAPK inhibitor.

    ≥98%
  • K1776

    Ketotifen Fumarate

    H1 histamine and LT antagonist, PDE inhibitor.<...

    ≥98%
  • I5992

    IOX2

    Prolyl hydroxylase inhibitor.

    ≥98%
  • L582694

    Lorlatinib

    Third generation macrocyclic ALK inhibitor.

    ≥98%
  • P1765

    Peptide Standard 1

    For use in amino acid analysis.

    ≥95%
  • B5561

    B-type Natriuretic Peptide (1-32), human

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥97%
  • M5727

    Moguisteine

    Potential ATP-sensitive K+ channel blocker, pot...

    ≥98%
  • A0910

    N-Acetyl-S-(N′-phenylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, antioxidant.

    ≥98%
  • B1855

    O6-Benzylguanine

    MGMT inhibitor.

    ≥98%
  • F4482

    Fluvastatin Sodium

    Statin; HMG-CoA reductase inhibitor, potential ...

    ≥98%
  • C1637

    Ceftriaxone Disodium Hemiheptahydrate

    β-lactam cephalosporin; penicillin binding pro...

    ≥98%
  • B465806

    BLU-667

    RET inhibitor.

    ≥98%
  • M3232

    Methylisoindigotin

    Indirubin derivative.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only